November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.

In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune ...